Cannabismarketcap

MariMed Inc Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for MRMD based on fundamentals, valuation multiples, and historical data.

$0.0560+0.18%
Neutral

Price Target Summary

Bear Case
$0.0494
-11.8% from current
Base Case
$1.06
+1793.9% from current
Bull Case
$1.91
+3309.0% from current

Technical Outlook

52-Week Range Analysis

$0.0520$0.16
Current: $0.0560
Support Level
$0.0628
Resistance Level
$0.15
From 52W High
-65.0%
From 52W Low
+7.7%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$171.0M
Year 2 Projected
$177.0M
Year 3 Projected
$181.6M

Based on +4.4% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
0.14x
Sector Median P/S
2.5x
Assessment
Undervalued vs sector

Cash Position

Cash on Hand
$8.4M
Total Debt
$82.7M

Key Metrics

Current Price$0.0560
Market Cap$22.6M
P/S Ratio0.14x
Revenue (TTM)$163.8M
Revenue Growth (YoY)+4.4%
Gross Margin35.6%
Cash on Hand$8.4M
Total Debt$82.7M
52W High$0.16
52W Low$0.0520

Signal Breakdown

Overall Signal: Neutral
  • Positive revenue growth
  • Healthy gross margins above 40%
  • Total debt exceeds cash position
  • Trading more than 50% below 52-week high
  • P/S ratio below sector median suggests upside

Risk Factors

  • High debt-to-cash ratio: total debt of $82.7M significantly exceeds cash of $8.4M.
  • Penny stock status (below $1.00) carries heightened volatility and delisting risk.

Analyst Summary

MariMed Inc (MRMD) is a multi-state cannabis operator (MSO) with growing revenue and a market capitalization of $22.6M. Based on trailing revenue of $163.8M and a P/S ratio of 0.14x, the stock appears undervalued relative to the sector median of 2.5x. Our algorithmic base-case price target of $1.06 implies upside of 1793.9% from current levels. The overall signal is neutral, with a mixed fundamental picture. Investors should weigh the 2 identified risk factors before making any investment decision.

Frequently Asked Questions

What is the price target for MRMD?+
Our algorithmic base-case price target for MariMed Inc (MRMD) is $1.06, with a bear case of $0.0494 and a bull case of $1.91. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is MRMD a buy right now?+
Based on our algorithmic analysis, MRMD currently carries a neutral signal. Positive revenue growth. Healthy gross margins above 40%. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for MariMed Inc?+
Based on the current year-over-year growth rate of +4.4%, we project MRMD revenue at $171.0M in Year 1, $177.0M in Year 2, and $181.6M in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in MRMD?+
High debt-to-cash ratio: total debt of $82.7M significantly exceeds cash of $8.4M. Penny stock status (below $1.00) carries heightened volatility and delisting risk.
How does MRMD valuation compare to the cannabis sector?+
MRMD has a trailing P/S ratio of 0.14x compared to the cannabis sector median of 2.5x. The stock undervalued vs sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to MRMD OverviewAll Cannabis Stocks